206 related articles for article (PubMed ID: 3058481)
21. Beta 2-microglobulin levels in cerebrospinal fluid of children with leukemia and lymphoma.
Pudek MR; Chan KW; Rogers PC; Teasdale JM
Clin Biochem; 1985 Jun; 18(3):180-3. PubMed ID: 3888445
[TBL] [Abstract][Full Text] [Related]
22. Elevated cerebrospinal fluid fibronectin concentration at diagnosis indicates poor prognosis in children with acute lymphoblastic leukemia.
Rautonen J; Koskiniemi M; Siimes MA; Salonen EM; Vaheri A
Int J Cancer; 1989 Jan; 43(1):32-5. PubMed ID: 2910830
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
Müller HL; Oh Y; Lehrnbecher T; Blum WF; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Aug; 79(2):428-34. PubMed ID: 7519190
[TBL] [Abstract][Full Text] [Related]
24. CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma.
Galicia N; Dégano R; Díez P; González-González M; Góngora R; Ibarrola N; Fuentes M
Expert Rev Proteomics; 2017 Apr; 14(4):363-372. PubMed ID: 28293970
[TBL] [Abstract][Full Text] [Related]
25. Significance of elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia.
Uozumi K; Ishitsuka K; Ohno N; Nakahara K; Utsunomiya A; Hanada S; Arima T
Leuk Lymphoma; 1995 Nov; 19(5-6):437-45. PubMed ID: 8590844
[TBL] [Abstract][Full Text] [Related]
26. Re-evaluation of the significance of cerebrospinal fluid human chorionic gonadotropin in detecting intracranial ectopic germinomas.
Tian C; Shi Q; Pu C; Huang X; Yu S; Zhang J; Huang D; Wang X; Liu R
J Clin Neurosci; 2011 Feb; 18(2):223-6. PubMed ID: 21163658
[TBL] [Abstract][Full Text] [Related]
27. Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.
Galicia N; Díez P; Dégano RM; Guest PC; Ibarrola N; Fuentes M
Adv Exp Med Biol; 2017; 974():85-96. PubMed ID: 28353226
[TBL] [Abstract][Full Text] [Related]
28. Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma.
Escudero L; Llort A; Arias A; Diaz-Navarro A; Martínez-Ricarte F; Rubio-Perez C; Mayor R; Caratù G; Martínez-Sáez E; Vázquez-Méndez É; Lesende-Rodríguez I; Hladun R; Gros L; Ramón Y Cajal S; Poca MA; Puente XS; Sahuquillo J; Gallego S; Seoane J
Nat Commun; 2020 Oct; 11(1):5376. PubMed ID: 33110059
[TBL] [Abstract][Full Text] [Related]
29. Brain metastases in malignant teratoma: a review of four years' experience and an assessment of the role of tumour markers.
Kaye SB; Bagshawe KD; McElwain TJ; Peckham MJ
Br J Cancer; 1979 Mar; 39(3):217-23. PubMed ID: 88952
[TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors.
Kopkova A; Sana J; Fadrus P; Slaby O
Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858
[TBL] [Abstract][Full Text] [Related]
31. Alpha-fetoprotein and beta-human chorionic gonadotropin: their clinical significance as tumour markers.
Gregory JJ; Finlay JL
Drugs; 1999 Apr; 57(4):463-7. PubMed ID: 10235686
[TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of cerebrospinal fluid beta 2-microglobulin determination in central nervous system leukemia].
Zhang HZ; Ye X; Sun ZG
Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):262-4, 313. PubMed ID: 2680338
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid human chorionic gonadotropin levels in normal pregnancy and choriocarcinoma.
Berkowitz RS; Osathanondh R; Goldstein DP; Martin PM; Mallampati SR; Datta S
Surg Gynecol Obstet; 1981 Nov; 153(5):687-9. PubMed ID: 7292268
[TBL] [Abstract][Full Text] [Related]
35. Human chorionic gonadotrophin immunoactivity in cystic intracranial tumours.
Honegger J; Mann K; Thierauf P; Zrinzo A; Fahlbusch R
Clin Endocrinol (Oxf); 1995 Mar; 42(3):235-41. PubMed ID: 7538923
[TBL] [Abstract][Full Text] [Related]
36. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.
Mahmoud HH; Rivera GK; Hancock ML; Krance RA; Kun LE; Behm FG; Ribeiro RC; Sandlund JT; Crist WM; Pui CH
N Engl J Med; 1993 Jul; 329(5):314-9. PubMed ID: 8321259
[TBL] [Abstract][Full Text] [Related]
37. Beta-2-microglobulin concentration in cerebrospinal fluid--monitoring of malignant lymphoma in the central nervous system.
Imagawa S; Aoki Y; Ninomiya H; Yoda Y; Abe T
Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1059-64. PubMed ID: 3904291
[No Abstract] [Full Text] [Related]
38. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia.
Henriksen LT; Nersting J; Raja RA; Frandsen TL; Rosthøj S; Schrøder H; Albertsen BK;
Br J Haematol; 2014 Jul; 166(2):213-20. PubMed ID: 24702187
[TBL] [Abstract][Full Text] [Related]
39. Soluble interleukin-2 receptor levels in cerebrospinal fluid of patients with acute lymphocytic leukemia or with non-Hodgkin's lymphoma.
Chang CS; Liu HW; Lin SF; Chen TP
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):132-7. PubMed ID: 2605973
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid beta-2-microglobulin level as marker of central nervous system involvement in lymphoma.
Pagano L; Marra R; Storti S; De Stefano V; Bizzi B
Haematologia (Budap); 1986; 19(2):121-5. PubMed ID: 3530906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
